JOVANA
Library Glossary Getting Started Three Levels Fields How it works Mission
Join the mission
All guides

Bile, the Gut, and Enterohepatic Recycling

Not everything leaves through the kidney. Meet the liver's bile route, the faecal exit, and the loop that keeps some drugs around far longer than you'd expect.

The liver's other job: dumping into bile

The liver does not only metabolise drugs — it also secretes some of them, intact or as metabolites, into bile. This is biliary excretion. Bile drains into the small intestine, so anything excreted this way travels down the gut and may leave the body in the stool (faecal excretion). The liver favours this route for larger molecules (roughly over 300–500 Da) and especially for drugs that have been conjugated — for example via glucuronidation in phase II metabolism.

The recycling loop

Here is the twist. A drug that was conjugated and dumped into bile arrives in the gut as, say, a glucuronide. Gut bacteria carry an enzyme (β-glucuronidase) that snips off the glucuronide, regenerating the original lipid-soluble drug. That free drug can now be reabsorbed across the gut wall, return to the liver in the portal blood, and start the cycle again. This loop is enterohepatic circulation.

Liver: drug + glucuronic acid  ->  drug-glucuronide  (conjugation)
        |
        v   (secreted into bile)
Bile -> Small intestine
        |
        v   gut bacteria: beta-glucuronidase cleaves it
        drug-glucuronide  ->  free drug  +  glucuronic acid
        |
        v   (reabsorbed across gut wall)
Portal blood -> back to Liver  ... loop repeats

Net effect: drug persists longer -> longer half-life
Enterohepatic circulation: conjugate in liver, cleave in gut, reabsorb, repeat. The loop prolongs a drug's stay.

Why the loop matters

Recycling means the drug is not truly eliminated on its first pass through bile — it keeps coming back. The practical consequence is a longer [[pharm-half-life|half-life]] and a more sustained effect than you'd predict from kidney handling alone. Drugs known for prominent enterohepatic recycling (such as some hormones, certain opioids, and ezetimibe) can show a 'double peak' in their concentration curve as the recycled fraction returns.